Clinical Impact and Cost-Effectiveness of Making Third-Line Antiretroviral Therapy Available in Sub-Saharan Africa-Reference-Cited by-同舟云学术

Clinical Impact and Cost-Effectiveness of Making Third-Line Antiretroviral Therapy Available in Sub-Saharan Africa

Published:2014-07-01 Issue:3 Volume:66 Page:294-302
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Ouattara Eric N.,Ross Eric L.,Yazdanpanah Yazdan,Wong Angela Y.,Robine Marion,Losina Elena,Moh Raoul,Walensky Rochelle P.,Danel Christine,Paltiel A. David,Eholié Serge P.,Freedberg Kenneth A.,Anglaret Xavier

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference33 articles.

1. . Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings.;Rawizza;Clin Infect Dis,2011

2. . Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Cote dIvoire.;Messou;J Acquir Immune Defic Syndr,2011

3. . Second-line antiretroviral therapy: long-term outcomes in South Africa.;Murphy;J Acquir Immune Defic Syndr,2012

4. . Second-line antiretroviral therapy in resource-limited settings: the experience of Medecins Sans Frontieres.;Pujades-Rodriguez;AIDS,2008

5. . Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.;Hosseinipour;HIV Med,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Virological outcomes of third-line antiretroviral therapy in a global context: a systematic reviews and meta-analysis;AIDS Research and Therapy;2024-06-25

2. Antiretroviral therapy;Viral Infections and Antiviral Therapies;2023

3. Cost-Effectiveness of antiretroviral therapy: A systematic review;Indian Journal of Public Health;2020

4. Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study;The Lancet HIV;2019-11

5. Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d’Ivoire: A model-based analysis;PLOS ONE;2019-06-27